This is indeed an interesting topic, and I thank the TUGgers who have personalized it -- we all read so much crap in the papers, and this is the real world experience here on TUG.
From the perspective of the corporate world, I do have a balancing view. I am the CFO of a healthcare company here in San Diego. We have several cardiac diagnostic tests that are widely utilized, and I would bet that any TUGger who has had open heart surgery or a stent implanted has been tested with our product. It is a life saving product and I am proud to be CFO of this company. I would without hesitation have our products used on me, my brother, my children, my parents, and know that they would have a better outcome because of these diagnostic tests.
In the United States, we sell our product directly to the hospital (and we have a U.S. sales force that we hire and pay to support those sales). Internationally, we sell through distributors, who in turn re-sell to the hospitals at a marked up price.
On average, we charge about 33% more from the products that we sell directly to the hospital in the United States than a hospital in Europe will ultimately pay for the same diagnostic test. The difference is because of the reimbursement amount that the hospital is paid by the insurance company. European insurers (ie, their governments) pay less to the hospital than a U.S. insurance company. Because of this, many European hospitals do not buy our products, preferring a cheaper (inferior?) product from a different source, purely for cost reasons. We've seen situations where sales in November and December dry up in the U.K. -- because the NHS ran out of budget for tests like ours and so procedures get canceled. Tough stuff if your open heart procedure is in November.
But why do we charge 33% more in the U.S. than we know is being paid in the rest of the world for the same test?
It's not greed -- this is part of the business model -- and although it is unfortunate, this is the reality of the situation: the United States subsidizes the rest of the world's health care systems. We spend ~$10M in R&D every year (about 25% of our Operating Expense budget) to try and create better tests. We hope to be successful, but it takes time and is uncertain. And that U.S. price premium funds it -- and the rest of the world will still get to buy that next generation test -- and pay less for it than the U.S. consumer.
There is alot of interest in a single payer system in the United States -- if every other country does it, why can't we? Well, this is a glimpse of what I believe would happen. The United States government, like every other government (and like Medicare) would reimburse less for the usage than current private insurers pay. There really would be decrease in new products, and budgets really would -- even more than today -- determine what treatments are available. Finally, fear of litigation is pervasive in the medical world -- we all recognize the need to protect our patients, but we need to recognize the significant related compliance cost that this brings from doctors and hospitals that fear litigation.
So I hope we fix what is currently broken, continue to protect those that are most vulnerable, reward those who have maintained coverage even if not sure they needed it, and manage the unnecessary costs that burden our products.
Sorry for the rambling message, and my thanks to my fellow TUGgers for sharing their experiences above.
Best,
Greg